Research Article

Human Bone Marrow Mesenchymal Stem Cell (hBMSCs)-Derived miR-29a-3p-Containing Exosomes Impede Laryngocarcinoma Cell Malignant Phenotypes by Inhibiting PTEN

Figure 4

HBMSC-derived Exo reduced laryngocarcinoma cell malignant progression. M4E and Hep2 cells were treated with hBMSC-derived Exo for 48 h. (a) CCK-8 assay. (b) Colony formation assay. (c) Transwell assay for detecting cell invasive and migratory rates. (d) Flow cytometry analysis of apoptotic rate. , , and .
(a)
(b)
(c)
(d)